S13 Ep8: Oncology PER® Spectives: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies for Melanoma
OncLive® On Air
00:00
Innovative Approaches in Melanoma Treatment
This chapter explores the groundbreaking use of oncolytic viruses for treating melanoma, especially in cases resistant to checkpoint inhibitors. The discussion includes the promising results from the Phase 2 IGNITE trial involving RP1 and Nivolumab, as well as the importance of collaboration between oncologists and interventional radiologists. Key considerations for patient eligibility, lesion selection, and the overall strategy for enhancing immune responses against melanoma are also highlighted.
Transcript
Play full episode
